Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FEMASYS INCFEMY · Entity 7510 | Director | June 24, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FEMASYS INC
Report date June 24, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.67 · Expires 2036-06-24 | Direct | 880 |
Reported balance
After 2026-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-24 · Grant · Acquired 880 · Balance 880 F1: The shares underlying the stock option vest one year from the date of grant, assuming continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the stock option vest one year from the date of grant, assuming continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Aug 12, 2026 00:58 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 880 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001140361-26-032339 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880 Underlying: Common Stock · 880 shares Expires 2036-06-24 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| March 19, 2026 Filed Mar 27, 2026 21:00 UTC | FEMASYS INC FEMY · Entity 7510 | GrantSeries D-1 Warrants · Derivative | 34,122 | Not disclosed Strike: $0.58 | Not disclosed |
DisclosureSEC source: 0001140361-26-011784 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,122 Underlying: Common stock, par value $0.001 per share · 34,122 shares Expires 2036-03-19 F1 · derivative.exercise_price: Holder may, at its option, exercise the Series D-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.58 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series D-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions. F3 · price: The reported securities were issued to the reporting person in a private placement as consideration in connection with that certain Omnibus Amendment and Consent Agreement, dated as of March 19, 2026 by and among the Company, the reporting person and the other parties thereto. F2 · derivative.underlying_shares: The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:27 UTC | FEMASYS INC FEMY · Entity 7510 | OtherSeries C-1 Warrants · Derivative | 34,122 | Not disclosed Strike: $1.10 | Not disclosed |
DisclosureSEC source: 0001140361-25-041720 · form4.xml · derivative · entry 4 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,122 Underlying: Common stock, par value $0.001 per share · 34,122 shares Expires 2035-11-07 F4 · derivative.exercise_price: Holder may, at its option, exercise the Series C-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $1.10 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series C-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions. F7 · price: The reported securities were purchased by the reporting person for an aggregate amount of $25,000. F6 · derivative.underlying_shares: The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:27 UTC | FEMASYS INC FEMY · Entity 7510 | OtherSeries B-1 Warrants · Derivative | 34,122 | Not disclosed Strike: $0.92 | Not disclosed |
DisclosureSEC source: 0001140361-25-041720 · form4.xml · derivative · entry 3 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,122 Underlying: Common stock, par value $0.001 per share · 34,122 shares Expires 2035-11-07 F3 · derivative.exercise_price: Holder may, at its option, exercise the Series B-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.92 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series B-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions. F7 · price: The reported securities were purchased by the reporting person for an aggregate amount of $25,000. F6 · derivative.underlying_shares: The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:27 UTC | FEMASYS INC FEMY · Entity 7510 | OtherSeries A-1 Warrants · Derivative | 34,122 | Not disclosed Strike: $0.81 | Not disclosed |
DisclosureSEC source: 0001140361-25-041720 · form4.xml · derivative · entry 2 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,122 Underlying: Common stock, par value $0.001 per share · 34,122 shares Expires 2035-11-07 F2 · derivative.exercise_price: Holder may, at its option, exercise the Series A-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.81 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series A-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions. F7 · price: The reported securities were purchased by the reporting person for an aggregate amount of $25,000. F6 · derivative.underlying_shares: The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:27 UTC | FEMASYS INC FEMY · Entity 7510 | OtherSenior Secured Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $0.73 | $25,000.00 |
DisclosureSEC source: 0001140361-25-041720 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common stock, par value $0.001 per share · 34,122 shares Expires 2035-11-07 F1 · derivative.exercise_price: Holder may, at its option, prior to maturity, convert all or any portion of the outstanding amount of Senior Secured Convertible Notes due 2035 (the "Convertible Notes"), including accrued paid in-kind interest thereon, subject to certain limitations, into shares of Common Stock, at an initial conversion price of $0.73 per share of Common Stock. The conversion rate is subject to adjustment in accordance with the terms of the Convertible Notes and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions. F7 · price: The reported securities were purchased by the reporting person for an aggregate amount of $25,000. F5 · derivative.underlying_shares: Represents the maximum number of shares of Common Stock issuable upon the voluntary conversion of the original stated amount of the Convertible Notes. The number of shares issuable upon conversion of the Convertible Notes is subject to increase in connection with the accrual of interest, which is payable in kind. The Holder's ability to convert the Convertible Notes to shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:25 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001140361-25-024007 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-06-25 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 19:51 UTC | FEMASYS INC FEMY · Entity 7510 | OtherCommon stock | 24,510 | $1.02 | $25,000.20 |
DisclosureSEC source: 0001140361-25-021412 · form4.xml · nonDerivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55.986 Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:37 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001140361-24-033181 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2034-07-12 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:15 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001140361-23-031165 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022651 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:53 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionSeries C Convertible Preferred Stock · Derivative | 10,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022194 · form4.xml · derivative · entry 3 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 10,587 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F1 · price: 10,587 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: 10,587 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: 10,587 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:53 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionCommon Stock | 10,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022194 · form4.xml · nonDerivative · entry 2 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 10,587 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:53 UTC | FEMASYS INC FEMY · Entity 7510 | PurchaseCommon Stock | 7,000 | $13.00 | $91,000.00 |
DisclosureSEC source: 0001140361-21-022194 · form4.xml · nonDerivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.